LOXL2 overexpression is observed in many human cancers, including gastric cancer [28], hepatocellular carcinoma (HCC) [29], breast cancer [30], and squamous cell carcinomas [31], and closely associated with their clinical-pathological characteristics and prognosis. The gene discussed is LOXL2; the disease is hepatocellular carcinoma.